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Late perforation of right atrium and aortic root after percutaneous
closure of patent foramen ovale
Gaetano Palma, MD, Felice Rosapepe, MD, PhD, Mariano Vicchio, MD, Veronica Russolillo, MD, Sabato Cioffi, MD,
and Carlo Vosa, MD, Naples, Italy
Open heart surgery has been the standard treatment forclosure of atrial septal defects (ASDs) for a half century.In the past decade a variety of devices for transcatheterclosure of ASDs have become available and an increas-
ing number of patients are treated by this alternative method.
Comparative studies have shown a shorter duration of hospital
stay associated with a lower rate of morbidity in patients who under-
went percutaneous occlusion than for those treated with classic sur-
gical procedures.1 Nevertheless, long-term follow-up has demon-
strated excellent outcomes in surgical repair,2 although late incidence
of device failure and emergency interventions must be analyzed.
We report a case of late perforation of the right atrium and the
aortic root by an Amplatzer device (AGA Medical Corp, Golden
Valley, Minn) used to close a patent foramen ovale (PFO), neces-
sitating an emergency surgical procedure.
Clinical Summary
A 28-year-old man with chest pain irradiating to the inferior maxillary
bone and interscapular region was brought to the territorial emergency
department. Thirteen months earlier, because of a history of cerebral
transitory ischemic attacks (TIAs), he had undergone an uncompli-
cated transcatheter PFO closure with an Amplatzer device at another
institution. On clinical examination, the patient was in hemodynam-
ically stable condition, the electrocardiogram showed ST-wave ele-
vation, and the echocardiogram demonstrated an important pericardial
effusion without evidence of cardiac tamponade and revealed the right
disc of the Amplatzer device leaning toward the aortic root. The
transesophageal echocardiogram and computed tomographic scan
confirmed that the left atrial disc of the device had perforated the left
atrium and aortic root. The patient was transferred to our institution
for the necessary emergency surgical procedure.
The operation was performed through a median sternotomy. Car-
diopulmonary bypass was established by ascending aortic and bicaval
cannulation. After antegrade cold cardioplegic arrest, we removed the
23-mm Amplatzer device and the adherent wall of the interatrial
septum (Figures 1 and 2). A transverse aortotomy was performed to
repair the laceration of the aortic root with stitches on pledgets. A
Dacron Sauvage patch was used to repair the interatrial septum. The
right atrium and the aortotomy were closed directly. The patient had
an uncomplicated postoperative recovery and was discharged 6 days
later.
Discussion
Percutaneous transcatheter closure of ASD or PFO has been per-
formed since 1976 as an alternative to conventional surgical repair
with various types of mechanical occluder devices.3 The Am-
platzer septal occluder is a model of such devices and was ap-
proved by the Food and Drug Administration in December 2001.
A good rate of successful closure has been reported. Nevertheless,
cases of late complications necessitating emergency surgical pro-
cedures have been described.4 Our patient had important anatomic
injuries. His hemodynamically stabile condition at the time of
surgical repair was a fortunate situation.
Classic open heart surgery remains the standard of care for ASD
repair with excellent outcomes since 1954, providing low operative
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doi:10.1016/j.jtcvs.2007.06.021 Figure 1. Intraoperative view of the Amplatzer device in the right
atrium.
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mortality and morbidity. Percutaneous closure is growing rapidly,
principally because of the patient’s, family’s, and pediatric cardiolo-
gist’s desire for a less invasive procedure. Considering the increase in
the number of procedures, a long-term follow-up is necessary to
evaluate the safety of mechanical occluders at long term. Our case
report described a complication that occurred 13 months after the
percutaneous procedure. The literature includes other authors report-
ing delayed heart perforation by the occluder device5; hence this
patient’s need for long-term echocardiographic follow-up to made an
early diagnosis of device failure and prevent emergency surgical
intervention. Finally, we conclude that patients should be informed
of the actual early and long-term results of surgical repair and
percutaneous approach to allow an informed decision.
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Complicated acute type B aortic dissection with
involvement of an aberrant right subclavian artery
and rupture of a thoracoabdominal aortic aneurysm,
Crawford type I: Successful emergency
endovascular treatment
Victor X. Mosquera, MD,a Milagros Marini, MD, PhD,b Fernando Rodríguez, MD,a
Ignacio Cao, MD,b and Alberto Juffé, MD, PhD,a A Coruña, Spain
Although an aberrant right subclavian artery (ARSA) isthe most common abnormality of aortic arch develop-ment, it is an unusual entity to encounter associated withthoracic aortic dissection. We report the successful en-
dovascular treatment of this association in a critically ill patient.
Clinical Summary
An 80-year-old man was referred
to our institution with the diag-
nosis of an acute aortic Stanford
type B dissection (Figure 1, A). The computed tomographic scan
images also showed a thoracoabdominal aortic aneurysm extend-
ing from an ARSA (Figure 1, B) to the esophageal hiatus (Craw-
ford type I).
Because of persistent back pain despite correct intravenous
treatment, a new computed tomographic scan was repeated 8 hours
later, revealing progression of the aortic dissection and the appear-
ance of a left-sided hemothorax. Blood analysis also showed a fall
of 10 points in the hematocrit value.
Because of the patient’s critical status and high surgical risk,
emergency endovascular treatment was indicated. Notwithstand-
ing, the procedure was technically demanding, because the en-
dograft had to be deployed while avoiding occlusion of the ARSA.
However, the diameter of the aortic aneurysm distal to the origin
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Figure 2. The removed Amplatzer device.
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